ArticleBreast cancer research and treatment2023

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis.

Roxanne A W Ploumen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.